Analytic Investors’s Ambev ABEV Stock Holding History

Analytic Investors’s Portfolio ABEV Stock Details ABEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-33,400	Closed	-$149K	–	593
2015 Q4	$149K	Buy	+33,400	New	+$163K	﹤0.01%	612

Other funds holding ABEV

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.8B AUM 25.03% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Analytic Investors's ABEV Position: Q1 2016 in Review

Analytic Investors sold out of Ambev (ABEV) in Q1 2016, closing a stake of 33,400 shares — an estimated $149K sold.

Analytic Investors first reported a position in ABEV in Q4 2015 and held it in 1 quarter. The position peaked at $149K in Q4 2015. 300 funds tracked by Wall St. Rank hold ABEV as of Q1 2016.

Analytic Investors reported no remaining Ambev position as of Q1 2016 after selling out during the quarter.
Analytic Investors sold 33,400 Ambev shares in Q1 2016, an estimated $149K.
Analytic Investors first reported a position in Ambev in Q4 2015 and held it in 1 quarter.
Analytic Investors's Ambev position peaked at $149K in Q4 2015.
300 funds tracked by Wall St. Rank held Ambev as of Q1 2016.

Based on Analytic Investors's 13F filing for Q1 2016, filed 20 May 2016.